NeuraceqActive Ingredient(s): Florbetaben
FDA Approved: * March 19, 2014
Pharm Company: * PIRAMAL IMAGING
Category: Diagnostic Aid
Florbetaben, a fluorine-18 (18F)-labeled stilbene derivative (formerly known as BAY-949172), trade name NeuraCeq, is a diagnostic radiotracer developed for routine clinical application to visualize β-amyloid plaques in the brain. It is indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD) and other causes of cognitive impairment. ^... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.